Sai Life Sciences Limited
Aditya Birla Sun Life Mutual Fund increased its stake in Sai Life Sciences Limited from 2.25% to 2.76%, buying 11.11 lakh shares. This increased its total holding to 58.67 lakh shares, valued at ₹83.44 Cr based on the share price of ₹1422.20. Aditya Birla Sun Life Mutual Fund was among several buyers in a block deal where TPG Asia VII SF Pte offloaded a 10% stake in Sai Life Sciences.
A contract research and manufacturing organization serving the pharmaceutical and biotechnology industries, Sai Life Sciences conducts research activities and produces customized solutions for clients globally. Incorporated in 1999, the company operates as a specialized service provider, offering integrated capabilities across drug development, formulation, and manufacturing to support its customers' product pipelines and commercial operations in India and international markets.
Joint venture between Aditya Birla Capital and Sun Life Financial of Canada. Among India's top five AMCs with over Rs 6.5 lakh crore in AUM across 100+ schemes. MD and CEO A. Balasubramanian is one of the most outspoken fund industry voices in India. CIO Mahesh Patil oversees the equity book with a consistent large and multicap tilt.